Willamette Valley Imaging, your medical imaging experts
About Willamette Valley Imaging
About WVI's Facility
WVI Patient Information
Referring Physician Information
WVI Billing and Insurance Information
Contact Board-Certified Radiologists at WVI
News and Media from WVI
Map & Directions to WVI

More Information

Magnetic Resonance

Computed Tomography

WVI Patient Information: Low-Dose CT Screening for Lung Cancer

WVI's multi-slice CT scanner

WVI's multi-slice CT scanner.

Willamette Valley Imaging now offers Low-Dose CT Screening for Lung Cancer.

Why is Lung Screening Important?

Lung cancer is the leading cause of cancer death in the U.S., with a 5-year survival rate of only 15%. A Low-Dose CT screening for lung cancer has a better potential to identify the disease at earlier stages of development and to reduce the risk of death due to lung cancer.

In fact, the National Cancer Institute found a 20% reduction in deaths from lung cancer among current or former heavy smokers who were screened with Low-Dose CT scans (National Lung Screening Trial, 2010).


It is recommended that the following persons have a CT Lung Screening performed:

Will this be covered by insurance?

Lung Cancer Screening CT scans require a physician referral, and are not currently covered by most insurance plans or Medicare. WVI is offering this service, including the interpretation and report by one of our board certified radiologists, for $225. Fee is paid at the time of service. WVI accepts cash, check and major credit cards.

Scheduling Appointments

Schedule Low-Dose CT lung screening exams by faxing the attached form to 541-344-9505, or schedule from our website.

Additional Guidelines

Additional guidelines for lung cancer screening using Low-Dose CT scans can be found here.

Lung Cancer Facts*

Lung Cancer is the leading cancer killer in both men and women in the U.S. In 1987, it surpassed breast cancer to become the leading cause of cancer deaths in women.

Lung Cancer causes more deaths than the next three mosst common cancers combined (colon, breast and prostate). An estimated 160,340 Americans were expected to die from lung cancer in 2012, accounting for approximately 28% of all cancer deaths.

The number of deaths due to lung cancer has increased approximately 4.3% between 1999 and 2008 from 152,156 to 158,656. The number of deaths among men has reached a plateau but the number is still rising among women. In 2006, there were 88,586 deaths due to lung cancer in men and 70,070 in women.

The age-adjusted death rate for lung cancer is higher for men (63.6 per 100,000 persons) than for women (39.0 per 100,000 persons). It is also higher for Blacks (53.4 per 100,000 persons) compared to Whites (50.2 per 100,000 persons). Black men have a far higher age-adjusted lung cancer death rate than White men, while Black and White women have similar rates.

Additional information on lung cancer screening for patients.

Additional information on lung cancer screening for physicians.

*Source: American Lung Association.